Low-field MRI covers a spectrum from traditional permanent-magnet open systems in the 0.2T to 0.7T range all the way to the emerging category of ultralow-field portable devices operating below 0.1T. Each segment has a distinct clinical rationale, a distinct patient population, and a distinct financing profile. The permanent-magnet open system at 0.3T or 0.5T is a mature technology with a well-established secondary market. The portable ultralow-field system at 64 mT or lower is a newer entrant with a different collateral story and a different buyer profile.
What unites them is the absence of superconducting magnet infrastructure. Low-field systems do not require liquid helium, do not carry cryogen costs, and have more modest RF shielding requirements than their higher-field counterparts. That simplicity reduces total project cost and makes the financing conversation more straightforward for practices that are not ready to take on a full superconducting installation.
We finance low-field MRI for orthopedic practices, chiropractic imaging providers, sports medicine clinics, and acute care facilities exploring bedside imaging options. The minimum transaction is $50,000; application-only approvals are standard for the lower end of this market. We also finance the newer generation of portable low-field devices for hospital and ICU applications.
Low-Field Technology: Two Distinct Segments
The first segment, permanent-magnet open systems, has been in clinical use for decades. Systems from manufacturers such as Esaote and Hitachi have a deep installed base in the 0.2T to 0.7T range. These are C-arm or H-frame configurations where the patient lies between two magnet poles in an open geometry. Image quality is adequate for musculoskeletal work; patient acceptance is high because there is no enclosed bore; and the siting requirements are minimal compared to a superconducting system.
The second segment, ultralow-field portable devices, is newer and represents a genuinely different clinical application. The Hyperfine Swoop, operating at 64 mT, was the first bedside MRI device cleared by the FDA for point-of-care neuroimaging. It does not require a shielded room and can operate in a standard ICU or emergency department bay. The image quality is not comparable to 1.5T or 3T, but for detecting hydrocephalus, hemorrhage, or midline shift in critically ill patients who cannot be safely transported to the scanner suite, it fills a real clinical gap.
The financing implications of these two segments differ. Permanent-magnet open systems are well-understood collateral with predictable residual values. Portable ultralow-field systems are newer assets whose long-term residual value is less established. Lenders approach them differently, which affects the advance rate and terms available.
Clinical Buyers for Low-Field Systems
Chiropractic practices and small orthopedic offices are the dominant buyers of permanent-magnet low-field systems. These buyers want in-house imaging capability for the MSK diagnoses their clinical work requires without the capital commitment of a superconducting installation. For a high-volume chiropractic clinic generating substantial self-pay and chiropractic benefit imaging, a low-field system at $150,000 to $300,000 can produce an attractive return on capital compared to continuing to refer patients out.
Hospitals and health systems exploring bedside neuroimaging are the primary buyers of the newer ultralow-field portable category. The ICU, emergency department, and stroke unit are the clinical environments where devices like the Hyperfine Swoop have found adoption. The value proposition is avoiding transport risk for unstable patients and enabling serial imaging that would be logistically impossible with a conventional scanner.
Veterinary practices are also active buyers of low-field open MRI systems. A 0.3T or 0.5T permanent-magnet system is commonly used for small-animal neurological and orthopedic imaging in specialty veterinary hospitals. We have financing structures that cover veterinary hospital MRI acquisitions, and the terms are comparable to human healthcare equivalents for well-qualified practices.
Financing Requirements for Low-Field Systems
Most low-field MRI transactions fall below $400,000, which means application-only approval is frequently within reach. A creditworthy principal, a practice with some operating history, and a clear equipment invoice are often the only requirements to get to approval on a same-day or next-day basis.
For the newer portable ultralow-field category, lenders may require a more detailed underwriting review because of the asset's limited resale history. The deal is still very much financeable, but we recommend building in a few additional days for the credit review to account for any lender questions about the technology.
Practices with credit challenges, including those with prior slow payments, a recent reorganization, or a credit score below what conventional banks require, can explore our B/C credit MRI financing program. The terms will reflect the credit profile, but the transaction is not automatically disqualified by a sub-700 credit score.
Frequently Asked Questions
Below are questions we hear from practices and hospital departments evaluating low-field MRI financing.
Finance Your Low-Field MRI System
Low-field MRI projects often close faster than high-field because the transaction size and documentation requirements are simpler. Share your project details with our team and we can have a financing proposal ready the same day. Contact us to get started.